Over the last three years South Africa’s President Jacob Zuma has made several promises to improve health care in his annual state of the nation address. This includes fighting TB, improving life expectancy and reducing maternal, infant and under five mortality. Health and Medicine Editor Candice Bailey asked a panel of academics to assess whether the promises have been kept.
11 February 2016 | The Conversation
This report reflects on the actions taken by cities and by the four core partners— the city of Paris, UNAIDS, the United Nations Human Settlements Programme (UN-Habitat) and the International Association of Providers of AIDS Care (IAPAC)—towards ending the AIDS epidemic as a public health threat by 2030.
24 January 2016 | UNAIDS
Surely a nod to the HIV and hepatitis C outbreaks in Indiana, Obama said he hopes the nation will battle prescription drug abuse and heroin abuse.
14 January 2016 | Poz magazine news
Among HIV-positive patients with Hodgkin lymphoma, a new study finds that blacks are significantly less likely than whites to receive treatment for the cancer, even though chemotherapy saves lives.
12 January 2016 | Eurekalert Medicine & Health
"We're here to encourage and support a new era of care in the HIV/AIDS world that is focused on the whole individual – holistic health and wellness, not just sickness and disease," said Neil Giuliano. "The model of care taking place at Strut will be replicated around the country and most likely around the world, just like the San Francisco model of care has been for 30 years."
07 January 2016 | Bay Area Reporter
“It’s been a lot of effort for something that shouldn’t be,” says John from Stockport. He’s educated himself about PrEP, chosen to import and pay for PrEP medicines himself, worked out which tests for side-effects he needs and battled with the NHS to get support. “None of this is really simple,” he says.
07 January 2016 | Prepster
They come from nearly every corner of the world. They are engaged in local communities and on the international scene. They include mothers, artists, a fugitive, a performer, and a drug smuggler. They are speaking out, acting up, and in some cases risking their personal safety and liberty.
06 January 2016 | My Fabulous Disease
Bristol-Myers Squibb Company today announced that it has entered into two individual agreements with ViiV Healthcare, a global HIV company, to divest its pipeline of investigational HIV medicines consisting of a number of programs at different stages of discovery, preclinical and clinical development. The agreements with ViiV Healthcare do not impact Bristol-Myers Squibb’s marketed HIV medicines, including Reyataz, Evotaz, Sustiva and Atripla. Bristol-Myers Squibb remains committed to the commercialization of these products and to those patients who rely on these medicines.
18 December 2015 | Bristol-Myers Squibb press release
In a major shakeup for the HIV/AIDS research community, the National Institutes of Health (NIH) today announced it will no longer support setting aside a fixed 10% of its budget—or $3 billion this year—to fund research on the disease. The agency also plans to reprogram $65 million of its AIDS research grant funding this year to focus more sharply on ending the epidemic.
15 December 2015 | Science
MSF today warned that life-saving antiretroviral medicines (ARVs) are routinely not making their way to patients in sub-Saharan Africa - most often despite sufficient stocks already being present in countries - and called for urgent improvements in ARV supply chains in the region.
30 November 2015 | MSF press release